This initiative funds multi-level and multi-domain intervention research aimed at reducing disparities in liver diseases and liver cancer among U.S. populations experiencing health disparities. Clinical trials are optional. The funding supports diverse eligible organizations including academic institutions, nonprofits, government entities, and small businesses, focusing on impactful research to address health inequities.
Eligible applicants include a wide range of U.S.-based organizations such as public and private institutions of higher education, nonprofits, government entities at various levels, small businesses, and Native American tribal organizations. Eligibility is limited to entities operating within the Uni
